Standard Biotools (LAB) Return on Capital Employed Growth (3y) (2014 - 2026)
Standard Biotools (LAB) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | - |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 370.00 |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,416.00 |
| Dec 31, 2025 | 760.00 |
| Sep 30, 2025 | 1,426.00 |
| Jun 30, 2025 | 2,821.00 |
| Mar 31, 2025 | 4,128.00 |
| Sep 30, 2024 | 2,999.00 |
| Jun 30, 2024 | 1,055.00 |
| Mar 31, 2024 | -683.00 |
| Dec 31, 2023 | -1,560.00 |
| Sep 30, 2023 | -914.00 |
| Jun 30, 2023 | -573.00 |
| Mar 31, 2023 | -952.00 |
| Dec 31, 2022 | -1,023.00 |
| Sep 30, 2022 | -1,751.00 |
| Jun 30, 2022 | -3,002.00 |
| Mar 31, 2022 | -4,278.00 |
| Sep 30, 2021 | -3,299.00 |
| Jun 30, 2021 | -1,018.00 |
| Mar 31, 2021 | 64.00 |